The MYCN 5' UTR as a therapeutic target in neuroblastoma
M. P. Volegova, L. E. Brown, U. Banerjee, R. Dries, B. Sharma, A. Kennedy, J. A. Porco, R. E. George
This study investigates the therapeutic potential of targeting eIF4A1 to inhibit MYCN expression in neuroblastoma by exploiting its role in translation of polypurine-rich 5' UTRs.
bioRxiv · Feb 20, 2024Cancer Biology